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ABSTRACT  
Peroxisome maintenance depends on the import of nuclear-encoded proteins from the cytosol. The 
vast majority of these proteins is destined for the peroxisomal lumen and contains a C-terminal 
peroxisomal targeting signal, called PTS1. This targeting signal is recognized in the cytosol by the 
receptor PEX5. After docking at the peroxisomal membrane and release of the cargo into the 
organelle matrix, PEX5 is recycled to the cytosol through a process requiring monoubiquitination of 
an N-terminal, cytosolically exposed cysteine residue (Cys11 in the human protein). At present, the 
reason why a cysteine, and not a lysine residue, is the target of ubiquitination remains unclear. 
Here, we provide evidence that PTS1 protein import into human fibroblasts is a redox-sensitive 
process. We also demonstrate that Cys11 in human PEX5 functions as a redox switch that regulates 
PEX5 activity in response to intracellular oxidative stress. Finally, we show that exposure of human 
 Version: Postprint (identical content as published paper) This is a self-archived document from i3S – Instituto de 
Investigação e Inovação em Saúde in the University of Porto Open Repository For Open Access to more of our 
publications, please visit http://repositorio-aberto.up.pt/  
 
A
0
1
/0
0
 
PEX5 to oxidized glutathione results in a ubiquitination-deficient PEX5 molecule, and that 
substitution of Cys11 by a lysine can counteract this effect. In summary, these findings reveal that 
the activity of PEX5, and hence PTS1 import, is controlled by the redox state of the cytosol. The 
potential physiological implications of these findings are discussed. 
INTRODUCTION  
Peroxisomes are multifunctional organelles that, among other functions, participate in cellular lipid 
and reactive oxygen species (ROS) metabolism (1,2). Defects in peroxisome function are at the core 
of several fatal genetic disorders (3). In addition, there is growing evidence that peroxisome biology 
and cellular aging are closely intertwined (4). For example, inhibition of the activity of catalase, the 
most abundant peroxisomal antioxidant enzyme, causes a cascade of accelerated aging reactions 
such as increased mitochondrial ROS production, oxidative damage to proteins and DNA, hyper-
secretion of matrix metalloproteinases, and impaired cell growth (5,6). On the other hand, 
increased cellular oxidative stress (e.g. during cellular aging) leads to a reduced import efficiency of 
peroxisomal matrix proteins containing a C-terminal peroxisomal targeting signal type 1 (PTS1), 
especially catalase (7). The molecular mechanisms underlying these phenomena are far from being 
understood. However, in this context, it should be mentioned that (i) under conditions of oxidative 
stress, PEX5, the shuttling import receptor for PTS1 proteins, accumulates at the peroxisome 
membrane and (ii) the cellular senescence phenotypes in old cells can be reversed by 
overexpression of catalase-SKL, a catalase derivative with enhanced peroxisome targeting 
efficiency (8). 
The assembly of functional peroxisomes requires the import of both membrane and matrix proteins 
(9). The vast majority of matrix proteins contain a PTS1. This class of proteins is synthesized on free 
polyribosomes in the cytosol and post-translationally recognized by the shuttling import receptor 
PEX5 while still in the cytosol. The PEX5- cargo protein complex then interacts with the peroxisomal 
docking/translocation machinery (DTM). This interaction ultimately leads to the insertion of PEX5 
into the DTM with the concomitant translocation of the cargo protein across the peroxisomal 
membrane. Interestingly, a 2-kDa N-terminal region of PEX5 containing a phylogenetically 
conserved cysteine residue remains exposed to the cytosol during this process. After cargo release, 
PEX5 is monoubiquitinated at this conserved cysteine residue (Cys11), and extracted from the DTM 
by the ATP-dependent receptor export module (REM) (10–12). Once back in the cytosol, the 
ubiquitin moiety attached to PEX5 is removed, probably by a combination of enzymatic and non-
enzymatic mechanisms (13,14). This resets PEX5 for the next round of import.  
Protein ubiquitination is a posttranslational modification that controls many intracellular processes 
(15,16). In general, this modification results in the attachment of a ubiquitin molecule to an ε-amino 
group of a substrate lysine residue (17). However, in a select set of proteins (e.g. PEX5), ubiquitin is 
transferred onto a cysteine residue yielding a thioester (18). The physiological relevance and role of 
this unconventional type of ubiquitination are puzzling. On one hand, it is well known that 
thioesters are easily disrupted by nucleophiles such as reduced glutathione (GSH) (19). On the other 
hand, it has been reported that substitution of the cysteine at position 11 by lysine in human PEX5 
results in a fully functional PTS1 import receptor, at least under standard laboratory conditions (13). 
Prompted by the combined observations that (i) PEX5 accumulates at the peroxisomal membrane 
upon oxidative stress (8), (ii) this peroxin needs to be monoubiquitinated at a conserved cysteine 
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residue in order to be exported back to the cytosol (20,21) and (iii) there is an ever increasing 
number of examples in which the activity of proteins (e.g. transcription factors, kinases, 
phosphatases, etc.) is controlled by the oxidation states of cysteines (22), we recently hypothesized 
that Cys11 in human PEX5 may serve as a functional redox switch regulating the 
peroxisomal/cytosolic localization of peroxisomal proteins such as catalase (2). In this report, we 
provide experimental evidence in favor of this hypothesis. 
Materials and Methods 
DNA manipulations and plasmids  
The mammalian expression vector pIRES2-EGFP and the restriction enzymes were commercially 
obtained from Westburg. Oligonucleotides (Table S1, Supporting Information) were synthesized by 
Integrated DNA Technologies. Polymerase chain reactions were routinely carried out by using Pfx 
DNA Polymerase (Invitrogen). The Escherichia coli strain Top10F’ (Invitrogen) was used for all DNA 
manipulations. The plasmids encoding a cytosolic roGFP2 (roGFP2; pMF1707), peroxisomal roGFP2 
(roGFP2-PTS1; pMF1706) or human catalase (pMF1525) have been described elsewhere (23). The 
pIRES2-roGFP2-PTS1 (pMN8) plasmid was constructed via a three-point ligation of the following 
fragments: (i) the XmaI/NotI-restricted backbone fragment of pIRES2- GFP, (ii) a XmaI/BamHI-
restricted polymerase chain reaction (PCR) fragment comprising the IRES2 sequence (template: 
pIRES2-EGFP2; primers: pIRES2fwXmaI and pIRES2rvBamHI) and (iii) the BamHI/NotI restricted 
fragment of pMF1706, which encodes roGFP2-PTS1. The bicistronic constructs encoding roGFP2-
PTS1 in combination with the large isoform of HsPEX5WT (pDC2) or HsPEX5C11K (pDC1) were 
generated by amplifying the corresponding HsPEX5-encoding cDNA fragments by PCR (templates: 
pMF1678 and pMF1578, respectively (13); primers: HsPex5.1fw and HsPex5.2rv) and cloning the 
BglII/SalI-digested PCR products into the BglII/SalI-restricted pIRES2-roGFP2-PTS1 vector. All 
plasmids were verified by DNA sequencing (LGC Genomics). The pGEM4(Promega)-based plasmids 
encoding the large isoform of human PEX5 and the mutated version of it possessing a lysine at 
position 11 (PEX5C11K) have been previously described (13,43). 
Cell culture, transfections and fluorescence microscopy  
The primary PEX5 null HuFs (cell line PBD005) have been described elsewhere (44,45). Briefly, these 
cells are homozygous for a mutation (Arg390Ter) in the PEX5 gene that results in a complete 
inactivation of PEX5’s normal function (44,45). Control HuFs were kindly provided by Dr. D. 
Cassiman (KU, Leuven, Belgium). Where indicated, the cell lines were transformed by introduction 
of SV40 large T-antigen. Unless specified otherwise, all cell lines were cultivated at 37◦ C in a 
humidified 5% CO2 incubator in minimum essential medium Eagle alpha (MEMα; Lonza) 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen), 2 mM Glutamax 
(Invitrogen), and MycoZap (Lonza). The cells were transfected by using the Neon Transfection 
System (Invitrogen; primary HuFs: 1200 V, 20-milliseconds pulse width, 1 pulse; transformed HuFs: 
1300 V, 30-milliseconds pulse width, 1 pulse). Cells for live cell imaging were seeded and imaged in 
FD-35 Fluorodish cell culture dishes (World Precision Instruments). The technical specifications of 
the objectives, excitation and emission filters, and digital camera have been described elsewhere 
(46). Ratiometric redox measurements were performed as described (23). Note that, as the spectral 
output of the replacement lamps was not always identical, the emission ratios of roGFP2 at the 400- 
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and 480-nm excitation wavelengths were expressed in arbitrary units (a.u.). The Olympus image 
analysis and particle detection software were used for quantitative image analysis. 
Peroxisome-dependent PEX5-ubiquitination assay  
35
S-labeled PEX5 and PEX5C11K were synthesized in rabbit reticulocyte lysates using the 
TNT®quick coupled transcription/translation system (Promega) in the presence of EasyTag™ L-
(
35
S)methionine (specific activity, >1000 Ci/mmol; PerkinElmer Life Sciences) and the pGEM4- 
based plasmids referred to above. Rat liver PNS (600 μg of protein) was diluted in import buffer 
(0.25 M sucrose, 50 mM KCl, 20 mM MOPS-KOH pH 7.2, 3 mM MgCl2, 20 μM methionine, and 2 
μg/mL N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobutylamide) containing 0.3 mM ATP (final 
volume 80μL), and primed for import by incubating the samples for 5 min at 37◦ C (47). The samples 
were placed on ice, and incubated for 10 min in the absence or presence of increasing 
concentrations oxidized glutathione (GSSG; added from a 0.1 M stock solution in 20 mM MOPS-
KOH, pH 7.4). In parallel, 1μL of 
35
Slabeled PEX5WT or PEX5C11K (diluted 1:20 (v/v) in import buffer) 
were also treated with the matching GSSG concentration. Next, the diluted lysates were added to 
the corresponding PNS mixtures, and the samples were incubated for 20 min at 37◦ C in the 
presence of 5 mM ATP and 7 μM glutathione S-transferase (GST)-ubiquitin (20). The reactions were 
stopped with 20 mM N-ethylmaleimide (NEM; 5 min on ice), diluted with 900μL of ice-cold SEMK 
buffer (0.25 M sucrose, 80 mM KCl, 20 mM MOPS-KOH, pH 7.2, 1 mM EDTA-NaOH, pH 8.0), and 
centrifuged at 16 000 × g for 20 min at 4◦ C to separate the organelles from soluble proteins. The 
organelle pellets were then subjected to SDS–PAGE under non-reducing (no DTT) and reducing (0.1 
M DTT) conditions, and analyzed by Western blot and autoradiography, as described before (13,20). 
Statistical analysis  
Statistics were performed on the VassarStats statistical computation website 
(http://vassarStats.net/). One-way analysis of variance was used to determine the differences 
among independent groups of numerical values, and individual differences were further explored 
with a Student’s t-test. The significance level was chosen to be p < 0.01. 
Results 
Redox regulation of PTS1 protein import into peroxisomes  
Previously, we and others have shown that there is a strong correlation between cellular aging, 
oxidative stress and PTS1 protein import into peroxisomes (7,8,23). To strengthen the concept that 
changes in the cellular redox state may have wide-ranging consequences for peroxisomal matrix 
protein import, we cultivated human fibroblasts (HuFs; passage 35) under different redox conditions 
and studied the subcellular localization of roGFP2-PTS1, a peroxisome-targeted variant of roGFP2 
(Figure 1A). RoGFP2 is a redox-sensitive form of the enhanced green fluorescent protein (EGFP) 
that contains two engineered cysteine residues on adjacent surface-exposed strands close to the 
chromophore (24). As (i) roGFP2 has two fluorescence excitation maxima at ∼400 and ∼490 nm 
and (ii) disulfide bond formation between the engineered cysteine residues leads to an increase in 
the excitation peak at ∼400 nm at the expense of the ∼490 nm peak, the ratio of roGFP2 emissions 
(at ∼510 nm) can provide a non-destructive read-out of the redox environment of the chromophore 
(24). To determine the effects of different treatments on the redox state of the cytosol, we 
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employed non-targeted, i.e. cytosolic, roGFP2 (23). We found that overexpression of catalase, a 
peroxisomal H2O2-decomposing enzyme whose activity drops during in vitro cellular aging (25), 
significantly lowers the redox state of the cytosol (Figure 1B) and largely restores PTS1 protein 
import (Figure 1C). A similar result was obtained when the cells were cultivated overnight in 
medium containing 0.5 mM dithiothreitol (DTT), a membrane permeable reducing agent (Figure 
1B,C). For comparison, we also included the values we obtained for these fibroblasts at passage 15 
(Figure 1B,C). Taken together, these findings lend support to the idea that the import of PTS1 
proteins into peroxisomes is a redox-regulated process. 
The redox-dependent changes in PTS1 import efficiency involve the evolutionarily conserved 
cysteine residue in the N-terminal domain of PEX5  
As (i) PTS1 proteins are imported into peroxisomes by the shuttling receptor PEX5 (9), (ii) this 
receptor accumulates at the peroxisomal membrane in aging cells (7), and (iii) the export of PEX5 
from the peroxisomal membrane to the cytosol depends on the evolutionarily conserved cysteine 
residue in the N-terminal region of the protein (20), we investigated whether or not this cysteine 
can act as a redox-sensitive regulatory switch for PEX5 activity. Therefore, we complemented late-
passage primary HuFs lacking functional PEX5 (hereafter called PEX5 null; for more details, see 
Materials and Methods) with constructs encoding human PEX5WT or PEX5C11K and determined 
how efficiently the expression of both PEX5 variants restored PTS1 protein import. The reasoning 
behind this experiment was that – in case Cys11 does indeed function as a redox switch – PEX5C11K, 
a peroxisomal import/export-competent protein (13), should restore PTS1 import more efficiently 
than PEX5WT in cells with an increased cytosolic redox state. To exclude the possibility that any 
observed differences are the indirect result of non-redox-regulated events, we also performed 
similar experiments in the corresponding transformed HuFs, which display a lower cytosolic redox 
state (see below). The results of these experiments are presented in Figure 2A. From these data, it is 
clear that (i) the import of roGFP2-PTS1 into peroxisomes is PEX5-dependent, (ii) PEX5WT is less 
functional in late-passage primary cells than in transformed cells and (iii) the replacement of 
cysteine at position 11 by a lysine in PEX5 dramatically increases its functionality in late-passage 
primary cells. To provide unambiguous evidence that the differences observed in primary and 
transformed cells expressing PEX5WT and PEX5C11K are redox-related and not simply due to 
differences in expression or stability of these PEX5 proteins, we confirmed that transformation of 
the PEX5 null HuFs led to a more reduced redox state of the cytosol (Figure 2B) and studied the 
effect of the thiol-reducing agent N-acetyl-cysteine (NAC) on the complementation activity of 
PEX5WT and PEX5C11K (Figure 3). Importantly, treatment of the cells with NAC, a compound that 
shifts the redox state of the cytosol toward lower values (26) (Figure 3A), resulted in an increased 
functionality of PEX5WT, but not of PEX5C11K (Figure 3B,C). Note that the results obtained for 
PEX5C11K also exclude the possibility that the differences in import kinetics observed for PEX5WT 
upon NAC treatment are the result of redox-related structural changes of the roGFP2-PTS1 reporter 
protein. All together, these experiments suggest that Cys11 of human PEX5 functions as a redox 
switch that modulates PEX5 activity in response to intracellular oxidative stress. 
Exposure of human PEX5 to oxidized glutathione impairs its monoubiquitination in a Cys11-
dependent manner  
To determine whether or not oxidation of human PEX5 affects its monoubiquitination at Cys11, we 
incubated 
35
S-labeled PEX5WT or PEX5C11K with a (peroxisome-containing) rat liver post-nuclear 
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supernatant (PNS) supplemented with ATP and GST-tagged ubiquitin (GST-Ub) in the absence or 
presence of increasing concentrations of oxidized glutathione (GSSG; for detailed procedures, see 
Materials and Methods). Organelles were then processed for SDS–PAGE under non-reducing and 
reducing conditions, and the amounts of 
35
S-labeled GST-Ub-PEX5 species that were produced in 
these in vitro assays were assessed by autoradiography (Figure 4). As shown in Figure 4 (upper 
panel), monoubiquitination of PEX5WT is much more sensitive to GSSG than monoubiquitination of 
PEX5C11K. Note that PEX5 monoubiquitination detected in these assays occurs at its residue 11, 
because treatment of protein samples with DTT destroys the thioester bond between GST-Ub and 
PEX5WT but not the amide bond that links GST-Ub to PEX5C11K (Figure 4, lower panel; see also 
13). The reduction in PEX5C11K monoubiquitination observed with the highest concentration of 
GSSG (Figure 4, upper panel) is probably due to the fact that the ubiquitination cascade comprises 
cysteine-containing enzymes (the ubiquitin-activating enzyme and ubiquitin-conjugating enzymes) 
that are also potential targets of GSSG (27). In summary, these data strongly indicate that Cys11 in 
human PEX5 is the most oxidative stress-sensitive cysteine of the complete PEX5 
monoubiquitination process. 
Discussion 
In this study, we have provided experimental evidence that (i) PTS1 protein import is a redox-
sensitive process, (ii) this redox sensitivity is mediated by PEX5, the shuttling receptor for 
peroxisomal matrix proteins, and (iii) the cysteine at position 11 in human PEX5 functions as a redox 
switch that regulates PEX5 activity in response to oxidative stress, most likely by modulating its 
monoubiquitination at the DTM. In summary, these findings provide a molecular explanation for 
the long-standing observation that peroxisomal PTS1 protein import is reduced in cells 
experiencing oxidative stress (7,28). In addition, as PEX5 monoubiquitination at Cys11 is necessary 
for the export of the receptor back into the cytosol (20,21), these data also explain why PEX5 
accumulates on peroxisomal membranes during cellular aging (7), a condition associated with a 
sharp increase in the cytosolic redox state (23,29). In the context of these results, it is important to 
recognize that also additional mechanisms may be at play in relation to the inhibitory effects of 
oxidative stress on peroxisomal protein import. For example, as oxidative stress can decrease both 
glycolytic and mitochondrial ATP production (30,31), it is very likely that this type of stress can also 
impede the ATP-dependent export step of PEX5 from the peroxisomal membrane to the cytosol. In 
addition, one can easily envisage a scenario in which oxidative stress leads to the modification and 
partial inactivation of non-PEX5-related components of the peroxisomal protein import and protein 
quality control machineries (32,33). However, as (i) such alternative mechanisms can be expected to 
equally reduce the functionality of PEX5WT and PEX5C11K and (ii) this is not the case in the 
experiments discussed here, they seem to be of no importance under the conditions studied. 
Over the years, accumulating evidence has strengthened the view that peroxisomal metabolism, 
cellular oxidative balance and cellular aging are intimately interconnected (2,4,34). In the context of 
this work, it is important to remember that Terlecky and colleagues in 2006 postulated the 
existence of a self-sustaining peroxisome deterioration spiral (35). According to this model, 
peroxisomes are predisposed to oxidative stress due to a dysregulated import of peroxisomal 
H2O2-producing oxidases, which in general bear a strong PTS1 (36), and catalase, which contains a 
weak PTS1 (37). This causes the organelle to slowly lose its ability to clear generated ROS, and – as 
such – its import machinery may become gradually compromised. This, in turn, will initially mainly 
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affect the import of weak substrates, such as catalase, but later on result in a self-perpetuating 
negative protein import spiral causing oxidative stress and peroxisome dysfunction (6,35). The data 
presented in this manuscript extend this theory by providing specific details regarding the potential 
mechanisms by which cellular oxidative stress causes peroxisomal protein import defects. Note 
that, as the monoubiquitinable cysteine residue in the N-terminus of PEX5 and the weak PTS1 of 
catalase are highly conserved in virtually all mammalian species (data not shown), it is tempting to 
speculate that these features have evolved because of a possible advantage. For example, a 
decrease in the peroxisomal import efficiency of (newly-synthesized) catalase may allow cells to 
rapidly respond to oxidative stress in the cytosol. This postulate is in line with a recent study 
showing that p97, an ATPase of the AAA family (ATPases with diverse cellular activities), can 
regulate H2O2 levels in the cytosol by affecting the retention time of (newly-synthesized) catalase 
within this subcellular compartment (38). 
Importantly, when the work presented in this manuscript was in a final stage, Subramani and 
coworkers reported that also Pichia pastoris Pex5 (PpPex5) functions as a redox-regulated PTS1 
protein import receptor (39). Specifically, these authors reported that Cys10, the evolutionarily 
conserved redox-sensitive cysteine in PpPex5, acts as a redox switch to control the binding and 
release of PTS1 proteins to and from PpPex5 by modulating its oligomeric state. On the basis of 
these observations and a report stating that the intraperoxisomal redox state is more reductive 
than that of the cytosol (40), the authors postulated a working model in which (oxidized) disulfide 
bond-linked PpPex5 binds newly-synthesized PTS1 proteins in the cytosol and releases these 
proteins upon reduction in the peroxisomal matrix. However, here it is important to note that this 
model is not compatible with our data. Indeed, we clearly show that the reduced functionality of 
PEX5 in an oxidizing environment can be counteracted by substituting Cys11 with lysine, and this 
finding in turn strongly indicates that – at least for human PEX5 – oxidation-mediated disulfide 
bond formation through this conserved cysteine can be functionally uncoupled from PTS1 cargo 
binding and release. In this context, it is also important to point out that some of us have previously 
shown that, in a mammalian system, (i) PTS1 proteins can be efficiently imported into peroxisomes 
under conditions in which the redox state of peroxisomes is more oxidizing than that of the cytosol 
(23), (ii) the release of PTS1 cargo proteins into the peroxisomal matrix is most likely triggered by 
binding of PEX14 to the 6th (and probably 7th) di-aromatic motif(s) of PEX5 (41) and (iii) PEX5C11A, 
a mutant of PEX5 that is not capable of forming a disulfide bond through the conserved cysteine, 
can translocate PTS1 proteins across the peroxisomal membrane and release these proteins into 
the organellar matrix as efficient as PEX5WT, at least in a cell-free in vitro import system (as 
PEX5C11A cannot be monoubiquitinated at the peroxisomal membrane and hence not be exported 
back to the cytosol, this protein abrogates PTS1 protein import upon expression in wild-type cells) 
(21,42). Nevertheless, as yeast and mammalian systems are not always directly comparable 
because of differences in PEX proteins and enzyme content (9), it remains to be established 
whether or not the apparently conflicting data obtained for PpPex5p and human PEX5 represent 
species- or condition-specific characteristics. In conclusion, our data provide clear evidence that (i) 
the activity of PEX5 depends on the redox state of the cytosol and (ii) this redox sensitivity is 
mediated by Cys11, an evolutionarily conserved amino acid involved in receptor monoubiquitination 
and recycling. These findings are relevant for a better understanding of how cellular oxidative stress 
may contribute to a demise of peroxisome function, a condition associated with cellular 
senescence, organismal aging and age-related diseases (4). 
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Figure 1: The efficiency of PTS1 protein import into peroxisomes is influenced by the cytosolic redox 
state. Primary HuFs (passages 15 or 35) were transiently transfected with a plasmid encoding 
peroxisomal (roGFP2-PTS1) or cytosolic (roGFP2) roGFP2, in combination or not with a plasmid 
encoding wild-type catalase (cat). The cells were cultivated in standard growth medium and, where 
indicated, supplemented with 0.5 mM DTT (overnight before analysis). A) Subcellular localizations 
of roGFP2-PTS1 in late passage cells. Note that, as (i) the cytosolic redox state of these cells 
displays a considerable intercellular variability (23), and (ii) this variability substantially influences 
the import efficiency of PTS1 proteins (this study), different cells can display a different distribution 
pattern for roGFP2-PTS1. PO, peroxisomes; C, cytosol; PO/C, peroxisomes and cytosol. Scale bar: 
10 μm. B) Box plot representations of the 400/480 nm fluorescence response ratios of roGFP2 at 6 
days post-transfection. The results are normalized to the average value of the ‘p15’ condition, which 
is set to one arbitrary unit (a.u.). The bottom and top of each box represent the 25th and 75th 
percentile values, respectively; the horizontal line inside each box represents the median; and the 
horizontal lines below and above each box denote the mean minus and plus one standard deviation, 
respectively. The number of randomly chosen measurements (from at least 6 different cells) is 
indicated below each box plot. The data were statistically compared. C) Distribution pattern of 
roGFP2-PTS1 at 3 days post-transfection: PO (black boxes), C (white boxes) or PO/C (grey boxes). 
The number of cells analyzed is indicated above each condition. 
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Figure 2: The cysteine at position 11 of human PEX5 mediates the oxidative stress-related decline in 
PTS1 import efficiency. Primary (P; passage number: 24) and SV40 T-antigen-transformed (T) PEX5 
null HuFs were transiently transfected with a plasmid encoding peroxisomal (roGFP2-PTS1) or 
cytosolic (roGFP2) roGFP2, in combination or not with a plasmid encoding HsPEX5WT (5WT) or 
HsPEX5C11K (5C11K). The cells were cultivated in the standard growth medium and analyzed 3 days 
post-transfection. A) Subcellular localizations of roGFP2-PTS1: peroxisomes (PO, black boxes), 
cytosol (C, white boxes) or peroxisomes/cytosol (PO/C, grey boxes); 100 randomly selected cells 
were analyzed per condition. B) Box plot representations of the 400/480 nm fluorescence response 
ratios of roGFP2. The results are normalized to the average value of the corresponding late-passage 
primary cells, which is set to one arbitrary unit (a.u.). The number of randomly chosen 
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measurements (from at least 10 different cells) is indicated below each box plot. For a description of 
these plots, see legend of Figure 1. The data were statistically compared. 
 
Figure 3: The efficiency of PTS1 protein import complementation in aged primary PEX5 null human 
fibroblasts is affected by the redox state of the cytosol and the identity of the ubiquitinatable 
residue near the N-terminus of human PEX5. Primary PEX5 null HuFs (passage number: 25) were 
transiently transfected with a monocistronic plasmid encoding cytosolic roGFP2 (roGFP2) or a 
bicistronic plasmid encoding peroxisomal roGFP2 (roGFP2-PTS1) and wild-type HsPEX5 (5wt) or 
HsPEX5C11K (5C11K). After 3 days, the standard growth medium was replaced by fresh medium 
supplemented (+NAC) or not (−NAC) with 1 mM NAC. The cells were analyzed at the indicated time 
points. A) Box plot representations of the 400/480 nm fluorescence response ratios of roGFP2. The 
results are normalized to the average value of the ‘0 h’ condition, which is set to one arbitrary unit 
(a.u.). The number of randomly chosen measurements (from at least 15 individual cells) is indicated 
below each box plot. For a description of these plots, see legend of Figure 1B. B and C) Subcellular 
localization of roGFP2-PTS1 under different treatment conditions (plotted as a function of time). 
PO, peroxisomal localization; PO/C, mixed peroxisomal and cytosolic localization. 
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Figure 4: Oxidized glutathione interferes with monoubiquitination of human PEX5 at Cys11. 
35
S-
labeled PEX5WT and PEX5C11K were subjected to in vitro import reactions (supplemented with 
GST-Ub) in the absence or presence of increasing concentrations of oxidized glutathione (GSSG) 
(for more details, see Materials and Methods). After 20 min, the samples were treated with NEM, 
and the organelles were isolated by centrifugation. The organelle fractions were subjected to SDS–
PAGE under non-reducing (−DTT) and reducing (+DTT) conditions, and blotted onto a nitrocellulose 
membrane. The membrane was exposed to an X-ray film. Lane I, 10% of the 
35
S-labeled PEX5 
reticulocyte lysate used in each lane. The numbers to the left indicate the migration of the 
molecular mass markers (in kDa). 
